Prospective memory functioning in individuals with Parkinson's disease: a systematic review
Alberto Costa1,2, Carlo Caltagirone2,3, Giovanni Augusto Carlesimo2,3
1a Psychology Department , Niccolò Cusano University , Rome , Italy.
The Clinical Neuropsychologist
|November 30, 2017
Summary
Prospective memory (PM) may be impaired in Parkinson
Area of Science:
- Neuroscience
- Cognitive Psychology
- Neurology
Background:
- Growing interest in prospective memory (PM) in Parkinson's disease (PD) without dementia.
- Evidence suggests potential PM impairment in this population.
- Understanding PM is crucial for cognitive health in PD.
Purpose of the Study:
- Review literature on PM functioning in PD.
- Discuss contributions of executive and episodic memory to PM deficits.
- Determine if PM impairment is independent or linked to mild cognitive impairment (MCI).
- Evaluate cognitive interventions for PM disorders in PD.
Main Methods:
- Systematic literature search for original research papers and reviews/meta-analyses on PM in PD.
- Analysis of 21 original research papers and 5 reviews/meta-analyses.
- Synthesis of findings on PM performance, contributing factors, and intervention efficacy.
Main Results:
- Executive functions and episodic memory are implicated in PD patients' PM performance.
- PM deficits may be associated with mild cognitive impairment (MCI), not universal in PD.
- Preliminary evidence suggests cognitive interventions can improve PM in PD patients with MCI.
Conclusions:
- PM assessment should be part of standard neuropsychological evaluation for PD patients.
- Cognitive interventions tailored to individual profiles may enhance PM abilities in PD.
- Further research is needed to solidify conclusions due to literature limitations.
Related Concept Videos
01:15Parkinson's Disease: Overview
2.1K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.1K
01:24Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
01:37Neural Regulation
43.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.5K
01:26Alzheimer's Disease: Overview
1.8K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.8K